Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0267964 (
PAA
)
2,561
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Nationally synthesized chemopreparations: phosphonoacetic (
PAA
), phosphonoformic (PFA) acids and acycloguanosine (Acg) exhibit a marked antiherpetic effect in cell cultures and marked protective effect in herpes
meningoencephalitis
in mice induced by intraperitoneal inoculation of herpes simplex virus type 1 (HSV-1) (43% PFA, 33%
PAA
, 25% Acg). Both in vitro and in vivo (mouse
meningoencephalitis
), PFA (its trisodium salt) on the whole proved to be less toxic than
PAA
but exerted a higher or similar antiherpetic effect. The combined use of pyrophosphate analogues (
PAA
, PFA) with Acg is more effective that their use separately both in vitro and in herpes
meningoencephalitis
in mice an produces an additive effect or one similar to it. Systemic inoculation of interferon inducers, lafarine or ridostine, is effective in herpes
meningoencephalitis
in mice induced by intraperitoneal inoculation of HSV-1 (the protective effect 33% and 26%, respectively). The combined use of ridostine and
PAA
in herpes
meningoencephalitis
in mice led to synergistic effect.
...
PMID:[Effectiveness of Soviet derivatives of phosphonic acid and their combination with interferon inducers in cell cultures and in a model of herpetic meningoencephalitis in mice]. 255 65